Lianyungang, China

Tiantian Li

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tiantian Li. Retrieved from https://idiyas.com/inventor/tiantian-li-v99u6ljd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tiantian Li: Innovator in Biopharmaceuticals

Introduction

Tiantian Li is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative therapeutic proteins. His work is recognized for its potential impact on cancer treatment and immunotherapy.

Latest Patents

Tiantian Li holds a patent for a bifunctional protein designed to target PD-1 and TGF-beta. This invention represents a promising advancement in the fight against cancer by enhancing the immune response.

Career Highlights

Li is currently employed at Chia Tai Tianqing Pharmaceutical Group Co., Ltd., a leading company in the pharmaceutical industry. His role involves research and development, focusing on creating effective treatments for various diseases.

Collaborations

Tiantian Li collaborates with esteemed colleagues, including Wei Zhao and Yingchun Li, who contribute to his research efforts. Their teamwork fosters an environment of innovation and shared knowledge.

Conclusion

Tiantian Li's work exemplifies the spirit of innovation in the biopharmaceutical sector. His contributions, particularly in developing therapeutic proteins, hold great promise for future medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…